Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 3.63473 | 60 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 2.9639 | 42 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 3.0099 | 43 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 3.40942 | 57 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 2.90615 | 41 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 3.01976 | 40 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 2.98342 | 40 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 2.93916 | 41 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 2.93414 | 41 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 2.95277 | 42 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 2.94736 | 41 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 2.92406 | 42 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 2.96077 | 41 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 2.92479 | 40 |